首页> 美国卫生研究院文献>Medical Journal Armed Forces India >Can hormone replacement therapy prior to oocyte donation cycle in women with premature ovarian failure improve pregnancy rate?
【2h】

Can hormone replacement therapy prior to oocyte donation cycle in women with premature ovarian failure improve pregnancy rate?

机译:卵巢早衰妇女在卵母细胞捐赠周期之前进行激素替代治疗可以改善妊娠率吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundInfertility is an important issue in women with Premature Ovarian Failure (POF). With no conclusive treatment available to enhance fertility in these women, it is the use of donor eggs with In-Vitro Fertilization (IVF) which can fulfil their desire to become a mother in a novel way. Hormone replacement therapy (HRT) in POF apart from correcting the endocrine defect also helps in improving the milieu of the uterus by improving its vascularisation and the sub endometrial blood flow. We thus aimed to carry out a study to find out whether hormone replacement therapy if administered prior to the oocyte donation cycle in patients of premature ovarian failure improves the pregnancy rate.
机译:背景不育是卵巢早衰(POF)妇女的重要问题。由于尚无确定的治疗方法可提高这些妇女的生育能力,因此使用了体外受精(IVF)的供体卵可以以新颖的方式满足她们成为母亲的愿望。 POF中的激素替代疗法(HRT)除了纠正内分泌缺陷外,还可以通过改善其血管形成和子宫内膜下血流来帮助改善子宫环境。因此,我们旨在进行一项研究,以发现如果在卵巢早衰患者的卵母细胞捐赠周期之前进行激素替代疗法是否可以提高妊娠率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号